South Korea will stop vaccinating people up to 50 years by the drug from the Coronavirus Astrazeneca due to the risk of heavy side effects in young people. This was reported by the Korean Agency for the Control and Prevention of Diseases (KDCA), RIA Novosti reports.
The age bar was raised after the country had confirmed two cases of death from thrombosis after the vaccine vaccine vaccine. It is noted that citizens under 50 years old who have already made the first injection by this drug will receive the second injection of the Pfizer vaccine.
June 22 reported that in South Korea, a 30-year-old man died from thrombosis with thrombocytopenia syndrome after vaccination with Astrazeneca. Heavy side effects in the form of nausea and headaches have appeared nine days after vaccination.
At the moment, Astrazeneca, Pfizer and Janssen vaccines are available in South Korea.
In April, some countries of Europe have suspended or banned vaccination with Astrazeneca due to the discovery of thrombosis in the attached patients. The company insisted on the safety of the drug. The European Medicine Agency (EMA) also said that the grounds for the failure of the Astrazeneca vaccine application.